-
Sunday House Call, #824, February 6, 2022: The “Death Receptor”; Type 1 Diabetes research, the real kind. #GoScience
Stories today: Newly discovered ‘death receptor’ could help drive type 1 diabetesNACI’s new guidance: Get fully vaccinated, even if previously infected with COVID-19 Your calls about: Precancerous scalp lesions – Actinic Keratoses Medical Assistance in Dying Sleep positions and heart health Use of Risedronate for osteoporosis. Is their a limit on therapy duration? Do you…
-
If the reported two-dose Pfizer pediatric COVID vaccine data to date for two to four-year-olds did not produce a strong enough immune response, do they have more data to support their application for FDA approval?
Medical Mythbusting Commentary for February 1, 2022 Source:Pfizer is expected to ask the F.D.A. to authorize its Covid vaccine for children under 5.
-
35 per cent of Canadians have received their third dose. Omicron is like Asimov’s Foundation series Mule who unexpectedly changed history upsetting the world view of many. Whereas two doses were good for Delta, three are needed now.
Medical Mythbusting Commentary for January 20, 2022 Source:Despite having enough doses for all, just 35 per cent of Canadians boosted
-
Small study (52 people) indicates that breakthrough COVID infections, not including omicron, in the fully vaccinated results in high levels of neutralizing antibodies.
Medical Mythbusting Commentary for December 21, 2021 Source:Breakthrough infection could mean ‘end game’ for COVID ‘Super Immunity’ From Breakthrough Infection After Covid-19 Vaccination? Here’s What This Study Said Reference:Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection
-
Ontario to expand eligibility of COVID-19 boosters for adults 50 and older finally recognizing that this is a three-dose vaccine. #VaccinesWork
Medical Mythbusting Commentary for December 2, 2021 Source:Ontario to expand eligibility of COVID-19 boosters for adults 50 and older amid rising case counts, sources say
-
Moderna CEO should quell their speculative and alarmist comments about Omicron. In times of uncertainty, statements should be calm, measured, humble, and neutral in tone. Answers likely forthcoming in 1-2 wks. Solutions will follow thereafter.
Medical Mythbusting Commentary for December 1, 2021 Source:Moderna CEO says COVID-19 vaccines may be less effective against Omicron variant BioNTech CEO says vaccine likely to protect against severe COVID from Omicron
-
Alzheimer’s prevention Phase 1 trial will look at safety of nasal vaccine. Much to happen before any conclusions can be drawn from this study. Also, @billcarrolltalk and I also discuss the approval of COVID vaccine for 5-11 year-old children.
Medical Mythbusting Commentary for November 22, 2021 Source:Nasal vaccine to treat Alzheimer’s disease to be tested in U.S. clinical trial COVID-19 vaccines for children
-
Sunday House Call #816, 11/21/21: “Some parents are understandably hesitant to vaccinate their young children. However, a choice not to get a vaccine is not a risk-free choice; rather, it’s a choice to take a different and more serious risk.” @DrPaulOffit
Health Canada approves Pfizer COVID vaccine for children 5 to 11 years of age. Here are the reasons why vaccination is important. It is a half truth that children are unaffected by the disease. Many weather the storm well but others, regardless of medical history, do not. We recommend vaccinations for many infectious disease that…
-
Moderna submits data to Health Canada for approval of its COVID-19 vaccine for children. Expect approval within weeks. I review with @billcarrolltalk why the dose is one-half of the adult version. #VaccinesWork
Medical Mythbusting Commentary for November 17, 2021 Source:Moderna asks Health Canada to approve its COVID-19 vaccine for children